ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023
Erratum: COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.